logo

For the Inventor, By the Inventor

New York, NY, United States of America

Scott Kanner

This inventor holds 6 USPTO granted patents and 4 published patent applications. Top assignee: Columbia University. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Kanner. Retrieved from https://idiyas.com/inventor/scott-kanner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal6 out of 2,560 
 
Columbia University
 patents

Years Active: 2024-2026

Loading Chart...
6 patents (USPTO):Explore Patents
1. 12559739 - Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes (2026-02-24),
2. 12351845 - Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes (2025-07-08),
3. 12351844 - Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes (2025-07-08),
4. 12312618 - Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes (2025-05-27),
5. 12091695 - Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes (2024-09-17),
6. 12084696 - Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes (2024-09-10),

Title: Scott Kanner: Innovator in Cellular Processes

Introduction

Scott Kanner is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cellular processes, holding a total of 6 patents. His work focuses on innovative methods and compositions that have the potential to impact medical treatments.

Latest Patents

One of Scott Kanner's latest patents is titled "Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes." This patent provides a recombinant engineered deubiquitinase (DUB) and outlines methods for treating or ameliorating inherited ion channelopathies, such as long QT syndrome, Brugada syndrome, or cystic fibrosis. Additionally, it includes methods for screening mutations that cause these inherited conditions, specifically targeting trafficking-deficient mutations that can be treated by the recombinant engineered DUB.

Career Highlights

Scott Kanner is affiliated with Columbia University, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential applications in treating complex medical conditions.

Collaborations

Scott Kanner collaborates with Henry M Colecraft, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Scott Kanner's contributions to the field of cellular processes through his innovative patents and collaborations highlight his role as a key inventor in medical research. His work continues to pave the way for advancements in the treatment of inherited ion channelopathies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…